Chronos is a CNS specialist company with a high concentration of expertise in both degenerative and behavioural diseases of the brain and nervous system. What we do: Chronos is an Oxford-based biotechnology company operating a semi-virtual R&D model to develop a portfolio of therapies in degenerative and behavioral brain diseases. The team utilises a network of industry- leading contract research organisations to develop NCEs and repurpose existing launched drugs. Chronos also has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, Chronoscreen™. Our Focus: - Acquisition, discovery and development of novel proprietary lead candidates. - Repositioning FDA/EMA approved drugs. Targets: - ALS (Lou Gehrig’s Disease) - Other Neurological Diseases - Fatigue - Addictive Behaviour